Highlights d GRAB NE sensors are genetically encoded GPCR activationbased norepinephrine sensors d GRAB NE distinguishes norepinephrine from dopamine with 1,000-fold specificity d The norepinephrine measurements are sensitive, with high spatiotemporal resolution d Norepinephrine dynamics are observed during stressful behaviors in zebrafish and mice SUMMARY Norepinephrine (NE) is a key biogenic monoamine neurotransmitter involved in a wide range of physiological processes. However, its precise dynamics and regulation remain poorly characterized, in part due to limitations of available techniques for measuring NE in vivo. Here, we developed a family of GPCR activation-based NE (GRAB NE ) sensors with a 230% peak DF/F 0 response to NE, good photostability, nanomolar-to-micromolar sensitivities, sub-second kinetics, and high specificity. Viral-or transgenic-mediated expression of GRAB NE sensors was able to detect electrical-stimulation-evoked NE release in the locus coeruleus (LC) of mouse brain slices, looming-evoked NE release in the midbrain of live zebrafish, as well as optogenetically and behaviorally triggered NE release in the LC and hypothalamus of freely moving mice. Thus, GRAB NE sensors are robust tools for rapid and specific monitoring of in vivo NE transmission in both physiological and pathological processes.
Correspondence
In Brief Feng et al. develop and validate a pair of genetically encoded GPCR-activationbased norepinephrine sensors, which, for the first time, enable specific in vivo measurement of norepinephrine dynamics during stressful behaviors with high spatiotemporal resolution in zebrafish and mice.
INTRODUCTION
Norepinephrine (NE) is a key monoamine neurotransmitter in the central nervous systems and peripheral organs of vertebrate organisms. It plays important roles in a plethora of physiological processes, allowing the organism to cope with its ever-changing internal and external environments. In the brain, NE is synthesized primarily in neurons of the locus coeruleus (LC), a small yet powerful nucleus located in the pons. Noradrenergic LC neurons project throughout the brain and exert a wide range of effects, including processing sensory information (Berridge and Waterhouse, 2003) , regulating the sleep-wake or arousal state (Berridge et al., 2012) , and mediating attentional function (Bast et al., 2018) . Blocking noradrenergic transmission causes impaired cognition and arousal and is closely correlated with a variety of psychiatric conditions and neurodegenerative diseases, including stress (Chrousos, 2009) , anxiety (Goddard et al., 2010) , depression (Moret and Briley, 2011) , attentiondeficit hyperactivity disorder (ADHD) (Berridge and Spencer, 2016) , and Parkinson's disease (PD) (Espay et al., 2014) . In the sympathetic nervous system, NE plays critical roles, such as regulating heart function (Brodde et al., 2001 ) and blood pressure (Zimmerman, 1981) .
Despite its clear importance in a wide range of physiological processes, the spatial and temporal dynamics of NE in complex Figure S1. (B) Identification of the most responsive NE sensor, NE0.5m (indicated by the black square), by screening the cpEGFP insertion sites in ICL3 of the a2AR. DF/F 0 refers to the peak change in fluorescence intensity in response to 100 mM NE.
(legend continued on next page) organs (e.g., the vertebrate brain) are poorly understood at the in vivo level due to limitations associated with current detection methods. Classic detection methods, such as microdialysiscoupled biochemical analysis (Bito et al., 1966; Justice, 1993; Watson et al., 2006) , have low temporal resolution (typically 5 min/collection) and complex sampling procedures, limiting the ability to accurately measure the dynamics of noradrenergic activity in the physiological state (Chefer et al., 2009) . Recent improvements in microdialysis-in particular, the introduction of the nano-LC-microdialysis method (Lee et al., 2008; Olive et al., 2000) -have significantly increased detection sensitivity; however, the sampling rate is still on the order of minutes. Electrochemical detection techniques, including fast-scan cyclic voltammetry (FSCV) based on measuring currents generated by the oxidation of NE (Bruns, 2004; Park et al., 2009; Robinson et al., 2008; Zhou and Misler, 1995) , provide nanomolar sensitivity and millisecond temporal resolution; however, their inability to distinguish NE from other monoamine neurotransmittersparticularly dopamine (Robinson et al., 2003) -presents a significant physiological limitation for measuring noradrenergic transmission both in ex vivo tissue preparations and in vivo. Both microdialysis-based and electrochemical techniques detect volume-averaged NE levels in the extracellular fluid and therefore cannot provide cell-type-specific or subcellular information.
Real-time imaging of NE dynamics would provide an ideal means to non-invasively track NE with high spatiotemporal resolution. A recent innovation in real-time imaging, cell-based neurotransmitter fluorescent engineered receptors (CNiFERs) (Muller et al., 2014) convert an extracellular NE signal into an intracellular calcium signal that can be measured using fluorescence imaging. However, CNiFERs require implantation of exogenous tumor cell lines and can report only volume transmission of NE. By contrast, genetically encoded sensors could, in theory, circumvent the above-mentioned limitations to provide fast, clear, non-invasive, and cell-type-specific reporting of NE dynamics. In practice, genetically encoded NE sensors developed to date either have poor signal-to-noise ratio and narrow dynamic range (e.g., a <10% change in fluorescence resonance energy transfer [FRET] ratio under optimal conditions) or lack in vivo characterization (Nakanishi et al., 2006; Patriarchi et al., 2018; Vilardaga et al., 2003; Wang et al., 2018b) , thus limiting their applicability in vivo.
To overcome these limitations, we developed a series of genetically encoded single-wavelength fluorescent GPCR activation-based NE (GRAB NE ) sensors with rapid kinetics, a DF/F 0 dynamic range of $200%, and EGFP-comparable spectra, brightness, and photostability. Here, we showcase the wide applicability of our GRAB NE sensors using a number of in vitro and in vivo preparations. In every application tested, the GRAB NE sensors readily reported robust and chemical-specific NE signals. Thus, our GRAB NE sensors provide a powerful imagingbased probe for measuring the cell-specific regulation of noradrenergic transmission under a wide range of physiological and pathological conditions.
RESULTS

Development and Characterization of GRAB NE Sensors
Inspired by the structure (Rasmussen et al., 2011a (Rasmussen et al., , 2011b and working mechanism (Chung et al., 2011; Manglik et al., 2015; Nygaard et al., 2013) of the b2 adrenergic G-protein-coupled receptor (GPCR), we exploited the conformational change between the fifth and sixth transmembrane domains (TM5 and TM6, respectively) upon ligand binding to modulate the brightness of an attached fluorescent protein. Building upon the successful strategy of generating GPCR activation-based sensors for acetylcholine (GACh) and dopamine (dLight and GRAB DA ; Patriarchi et al., 2018; Sun et al., 2018) , we first screened human adrenergic receptors for a potential scaffold. We inserted circular permutated EGFP (cpEGFP) into the third intracellular loop domain (ICL3) of three a-adrenergic receptors (a1DR, a2AR, and a2BR) and two b-adrenergic receptors (b2R and b3R; Figure 1A ). Among these five constructs, a2AR-cpEGFP had the best membrane trafficking, indicated by its high colocalization ratio with membrane-targeted RFP (Figure S1); we therefore selected this receptor as the scaffold for further development.
The length and amino acid composition of the linkers surrounding the cpEGFP moiety inserted in green fluorescent genetically encoded Ca 2+ indicators for optical imaging (G-GECO) (Zhao et al., 2011) , GCaMP (Akerboom et al., 2012) , GACh , and GRAB DA (Sun et al., 2018) affects the fluorescence response of cpEGFP-based indicators. Thus, we systematically truncated the linker, which starts with the entire flexible ICL3 of a2AR surrounding cpEGFP ( Figure 1B) . We initially screened 275 linker-length variant proteins and identified a sensor (GRAB NE0.5m ) truncated at the S295 and R360 sites of a2AR with a modest response to NE ( Figure 1B, right) . From this prototype, we screened random mutations of seven amino acids close to the cpEGFP moiety: two (GG) on the N-terminal and five (GGAAA) on the C-terminal side of cpEGFP ( Figure 1C) . Among approximately 200 mutant candidates generated from GRAB NE0.5m , we found GRAB NE1m , which contains a glycine-to-threonine mutation at position C1, and exhibited the best performance with respect to DF/F 0 and brightness ( Figure 1C , middle and right). We hypothesize that GRAB NE (C) Optimizing the GRAB NE sensors by mutational screening of the insertion linker. NE0.5m was used as a template, and the indicated amino acids on N-terminal and C-terminal sides of the cpEGFP insert were mutated individually. Sensor GRAB NE1m (indicated by the pink squares) was identified due to having the strongest response (DF/F 0 ) and brightness relative to the original NE0.5m sensor (indicated by the dashed line at 1.0). (D) Tuning the sensor's affinity for NE by introducing mutations in the GPCR. Magnified views of the ligand-binding pocket from the cytosol are shown; key residues involved in ligand binding and inducing a conformational change upon ligand binding are indicated. The middle shows example images of HEK293T cells expressing the indicated GRAB NE sensors; EGFP fluorescence is shown in the left column, and the fluorescence response in the presence of 100 mM NE is shown in the right column. Shown at the right are the normalized dose-response curves for the three GRAB NE sensors, with EC 50 values (top) and the average fluorescence change in response to 100 mM NE (bottom); n = 21-67 cells from 3-5 cultures for each sensor. The scale bars in (A) and (D) represent 10 mm. Unless noted, values with error bars indicate mean ± SEM. ***p < 0.001 (Student's t test). See also Figure S1 . shares a similar mechanism of fluorescence modulation as GCaMP sensors (Akerboom et al., 2009 (Akerboom et al., , 2012 . Namely, ligand binding induces a conformational change of the binding protein (i.e., CaM in GCaMP), which alters the chemical environment, causing de-protonation of the cpEGFP chromophore and the resulting increase in fluorescence.
We expressed GRAB NE1m in HEK293T cells and applied NE at different concentrations. NE induced a fluorescence change in GRAB NE1m -expressing cells in a dose-dependent manner, with a half maximal effective concentration (EC 50 ) of 930 nM and a maximum DF/F 0 of approximately 230% in response to a saturating concentration of NE (100 mM; Figure 1D , middle and right). We also introduced mutations in a2AR in order to increase its NE detection sensitivity. We found that a single T6.34K point mutation (Ren et al., 1993) -which is close to the highly conserved E6.30 site-resulted in a 10-fold increase in sensitivity (EC 50 $83 nM) to NE compared with GRAB NE1m . This sensor, which we call GRAB NE1h (following the naming convention of GRAB DA , ''m'' means medium and ''h'' means high affinity; Sun et al., 2018) , had a maximum DF/F 0 of $130% in response to 100 mM NE. As a control, we also generated GRAB NEmut , which has the mutation S5.46A at the putative ligand-binding pocket and therefore is unable to bind NE ( Figure 1D ); this control sensor has similar brightness and membrane trafficking (Figures S1 and S2A) but does not respond to NE even at 100 mM ( Figure 1D , middle and right).
We examined whether our GRAB NE sensors can capture the rapid dynamic properties of NE signaling, including its release, recycling, and degradation. We bathed GRAB NE1h -expressing HEK293T cells in a solution containing 1-(2-nitrophenyl) ethoxycarbonyl (NPEC)-caged NE. A focused spot of 405-nm light was applied to locally uncage NE by photolysis ( Figure 2A ). Transient photolysis induced a robust increase in fluorescence in GRAB NE1h -expressing cells (mean on time constant 137 ms; single exponential fit), which was blocked by application of the a2-adrenergic receptor antagonist yohimbine (Figures 2B and 2C) . To characterize both the on and off rates (t on and t off , respectively) of the GRAB NE sensors, we locally and subsequentially applied NE and yohimbine to GRAB NE -expressing cells using rapid perfusion and measured the fluorescence response using high-speed line scanning ( Figures 2D and 2E ). The average delay of the perfusion system itself (measured by fitting the fluorescence increase in the co-applied red fluorescent dye Alexa 568) was 34 ms ( Figure 2F ). Fitting the fluorescence change in each sensor with a single exponential function yielded an average t on of 72 and 36 ms for GRAB NE1m and GRAB NE1h , respectively, and an average t off of 680 and 1,890 ms for GRAB NE1m and GRAB NE1h , respectively ( Figures 2E and 2F ). The faster on rate and slower off rate of GRAB NE1h compared to GRAB NE1m are consistent with its relatively higher affinity for NE.
High ligand specificity is an essential requirement for tools designed to detect structurally similar monoamine-based molecules. Importantly, our GRAB NE sensors, based on a2AR, responded to both NE and epinephrine (Epi), but not other neurotransmitters around physiological concentrations ( Figure 2G ). The sensors also responded to the a2AR agonist brimonidine, but not the b2-adrenergic receptor agonist isoprenaline, indicating receptor-subtype specificity. Moreover, the NE-induced fluorescence increase in GRAB NE -expressing cells was blocked by the a-adrenergic receptor antagonist yohimbine, but not the b-adrenergic receptor antagonist ICI 118,551. Because NE and dopamine (DA) are structurally similar yet functionally distinct, we characterized how our GRAB NE sensors respond to various concentrations of DA and NE. Wild-type a2AR has an 85-fold higher affinity for NE versus DA ( Figure 2H , right). Our GRABs bracketed this selectivity, with GRAB NE1m at 350-fold higher affinity for NE, whereas GRAB NE1h had a 37-fold higher affinity for NE ( Figure 2H , left and middle). In contrast, FSCV was unable to differentiate between NE and DA, producing nearly identical responses to similar concentrations of NE and DA (Figures 2I and S2D; Robinson et al., 2003) . To test photostability, we continuously illuminated GRAB NE -expressing HEK293T cells using either 1-photon (confocal) or 2-photon laser microscopy and found that GRAB NE sensors were more photostable than EGFP under both conditions ( Figure S2C ). Taken together, these data suggest that the GRAB NE sensors can be used to measure the dynamic properties of noradrenergic activity with high specificity for NE over other neurotransmitters.
Next, we examined whether our GRAB NE sensors trigger GPCR-mediated downstream signaling pathways. Bathing GRAB NE1m -expressing cells in a saturating concentration of NE for 2 h resulted in no internalization of GRAB NE1m ( Figure 2J ). Consistent with this, both GRAB NE1m and GRAB NE1h induced little b-arrestin-mediated signaling in a TANGO assay, even at the highest concentration of NE tested ( Figure 2K ), suggesting no coupling to b-arrestin signaling. In addition, GRAB NE1m and GRAB NE1h had drastically reduced downstream Gi coupling compared to wild-type a2AR, which was measured using a Gi-coupling-dependent luciferase complementation assay (Figure 2L; Wan et al., 2018) . We also found that G protein activation by GRAB NE1m measured by the highly sensitive transforming growth factor a (TGF-a) shedding assay was reduced by about 100-fold compared to the wild-type receptor a2AR ( Figure S2B ; Inoue et al., 2012) . Finally, blocking G protein activation by treating cells with pertussis toxin ( Figure 2M ) had no effect on the fluorescence response of either GRAB NE1m or GRAB NE1h , indicating that the fluorescence response of GRAB NE sensors did not require G protein coupling (Rasmussen et al., 2011a) . Taken together, these data indicate that GRAB NE sensors can be used to report NE dynamics without inadvertently engaging GPCR downstream signaling.
Characterization of GRAB NE Sensors in Cultured Neurons
The expression, trafficking, and response of proteins can differ considerably between neurons and cell lines (Marvin et al., 2013; Zou et al., 2014) . To characterize the performance of GRAB NE sensors in neurons, we co-expressed GRAB NE together with several neuronal markers in cultured cortical neurons. Both GRAB NE1m and GRAB NEmut trafficked to the cell membrane and colocalized with the membrane-targeted marker RFP-CAAX ( Figures 3A and 3B ). Upon bath application of a saturating concentration of NE, GRAB NE1m and GRAB NE1h had a peak DF/F 0 of approximately 230% and 150%, respectively, whereas GRAB NEmut had no response ( Figures 3D and 3E (D-F) NE was applied to HEK293T cells (D) expressing GRAB NE1m or GRAB NE1h to measure t on . Yohimbine (YO) was then applied in order to measure t off ; representative traces (E) and quantification data (F) are shown; the white dotted line indicates the line-scanning region. n R 6 cells from 6 cultures. (G) The indicated compounds were applied to GRAB NE1m and GRAB NE1h , and the change in fluorescence relative to NE is plotted. (H) Dose-response curves for GRAB NE1m , GRAB NE1h , and wild-type a2AR for NE and DA, with EC 50 values shown; n R 3 wells with 100-300 cells each. (I) Fast-scan cyclic voltammetry measurements in response to increasing concentrations of NE and DA. The insets show exemplar cyclic voltammograms of NE and DA at 100 mM, with peak current occurring at $0.6 V. (J) Time course of DF/F 0 for GRAB NE sensors measured over a 2-h time frame; note that the fluorescent signal remained at the cell surface even after 180 min, indicating no measurable internalization or desensitization. n = 2 wells with 100-300 cells each. (K) A TANGO assay was performed in order to measure b-arrestin-mediated signaling by GRAB NE1m , GRAB NE1h , and wild-type a2AR in the presence of increasing concentrations of NE; n = 4 wells with R10 5 cells each. (L and M) GRAB NE sensors do not couple to downstream G protein signaling pathways. (L) Wild-type a2AR, but not GRAB NE1m or GRAB NE1h , drives Gai signaling measured using a luciferase complementation assay; n = 3 wells with R10 5 cells each. responses in GRAB NE1m -expressing cells were similar among various subcellular compartments identified by co-expressing GRAB NE1m with either the axonal marker synaptophysin (SYP) or the dendritic marker PSD95, suggesting that GRAB NE sensors enabled the detection of NE throughout the neurons ( Figure 3C ). Both GRAB NE1m -and GRAB NE1h -expressing neurons had a dose-dependent fluorescence increase in response to NE, with mean EC 50 values of 1.9 mM and 93 nM, respectively (Figure 3F) . Consistent with high selectivity for NE, GRAB NE1m , and GRAB NE1h had a 1,000-fold and 7-fold higher affinity, respectively, for NE versus DA ( Figure 3F ). Moreover, GRAB NE1m responded specifically to NE and Epi, but not to several other neurotransmitters and ligands, including isoprenaline, histamine, dopamine, and serotonin ( Figure 3G ). Similar to our results in HEK293T cells, inhibiting G protein activation with pertussis toxin did not affect the NE-induced fluorescence change in GRAB NE1m in cultured neurons ( Figure S2E ), suggesting G protein coupling was not involved in the fluorescence change of GRAB NE1m . Finally, bathing GRAB NE1m -expressing neurons in 100 mM NE for 2 h did not cause detectable internalization of the sensor. The fluorescence increase was stable for the entire period and blocked completely by yohimbine ( Figures 3H and 3I ). Thus, our GRAB NE sensors have the necessary affinity and specificity to faithfully measure noradrenergic signaling in neurons.
Characterization of GRAB NE Sensors in Both Cultured and Acute Brain Slices
To further test the performance of GRAB NE sensors in vitro, we expressed GRAB NE1m and GRAB NE1h in cultured hippocampal slices using a Sindbis virus expression system ( Figure S3A ). In both GRAB NE1m -and GRAB NE1h -expressing CA1 neurons, exogenous application of NE in artificial cerebrospinal fluid (ACSF)-but not ACSF alone-evoked a robust increase in fluorescence ( Figures S3B-S3D ). In contrast, NE had no detectable effect on GRAB NEmut -expressing neurons (Figures S3C and S3D) . Application of several a-adrenergic receptor agonists, including epinephrine and brimonidine, also generated fluorescence increases in GRAB NE1m -expressing neurons (Figures S3C and S3F) , consistent with data in cultured cells. The rise and decay kinetics of the change in fluorescence were second order, which reflects the integration of the time required to puff the drugs onto the cells and the sensor's response kinetics ( Figures S3E and S3G ). To test whether overexpression of NE sensors may affect endogenous NE receptors, we made simultaneous dual patch-clamp recordings and fluorescence imaging from pairs of neighboring GRAB NE1m -expressing and control non-expressing CA1 neurons ( Figure S3H ). Brief 10-ms NE puff applications evoked a large outward current in GRAB NE1mexpressing and non-expressing neurons, as well as a concurrent fluorescence signal in GRAB NE1m -expressing neurons, but not in control non-expressing neurons ( Figures S3I-S3L ). The NE receptor-mediated outward currents had the same amplitude, latency, signal-to-noise ratio, desensitization, rise time, and decay time constant in GRAB NE1m -expressing and control nonexpressing neurons ( Figures S3I-S3L and S3M-S3O), suggesting no effect of overexpression of GRAB NE1m on endogenous NE receptor function. Notably, GRAB NE1m detected faster NE signals prior to the electrophysiologically recorded NE-activated outward currents. We also prepared acute hippocampal slices in which GRAB NE1h was expressed using an adeno-associated virus (AAV); in this acute slice preparation, GRAB NE1h -expressing hippocampal neurons are innervated by noradrenergic fibers, which was confirmed by post hoc staining using an antibody against dopamine beta hydroxylase ( Figures S4A and S4B ). Application of electrical stimuli at 20 Hz for 1 s elicited a robust increase in GRAB NE1h fluorescence, and this increase was blocked by the application of yohimbine ( Figure S4C ). Consistent with our results obtained using cultured slices, exogenous application of various a-adrenergic receptor agonists, including NE, Epi, and brimonidine-but not the b-adrenergic receptor agonist isoprenaline-evoked a fluorescence increase in GRAB NE1h -expressing neurons, and this response was blocked by yohimbine, but not by the b-adrenergic receptor antagonist ICI 118,551 (Figure S4D) . To examine whether expression of GRAB NE sensors would alter neurons' physiology, we also compared the calcium signals between GRAB NE1h -expressing neurons and control non-expressing neurons in acute hippocampus slices ( Figures  S4E-S4I ). Overexpression of a high-affinity version of GRAB NE sensor (GRAB NE1h ) did not alter the high potassium-induced calcium signals ( Figures S4G-S4I ), indicating no apparent perturbation on the excitability of neurons when overexpressing GRAB NE.
We examined whether our GRAB NE sensors can be used to monitor the dynamics of endogenous NE. We expressed GRAB NE1m in the locus coeruleus (LC) ( Figure 4A ), which contains the majority of adrenergic neurons within the brain, and activation of LC neurons by salient stimuli, including physiological stress, looming, and electrical stimulation, concomitantly releases NE throughout many brain regions (Berridge and Waterhouse, 2003; Dugast et al., 2002; . (legend continued on next page) 2 weeks after AAV injection, we prepared acute brain slices and observed GRAB NE1m expression in the membrane of LC neurons using two-photon microscopy ( Figure 4A ). We then used electrical stimuli at 20 Hz to evoke the release of endogenous NE in the LC in the acute slices. Increasing the number of stimuli caused progressively stronger responses ( Figure 4B ). To estimate the concentration of NE after electrical stimulation, we also perfused the same slices with different concentrations of exogenous NE. Based on the calibration curve, we estimated that the volumeaveraged NE concentration (NE Vol ) was 0.17 ± 0.04 mM and 0.56 ± 0.13 mM when stimulated with 2 or 20 pulses at 20 Hz, respectively ( Figures S4J-S4M ). Application of the voltageactivated potassium channel blocker 4-aminopyridine, which increases Ca 2+ influx during action potentials, significantly increased the fluorescence response, whereas application of Cd 2+ to block calcium channels abolished the stimulationinduced fluorescence increase ( Figure 4C ), consistent with presynaptic NE release being mediated by Ca 2+ influx. We also performed line-scanning experiments in order to track the kinetics of endogenous NE release ( Figure 4D , left). A brief electrical stimulation induced a rapid fluorescence response with a mean t on and t off of 37 ms and 600 ms, respectively ( Figure 4D , middle and right). Taken together, these data indicate that GRAB NE1m can be used to monitor the release of endogenous NE in real time. NE released into the synaptic cleft is recycled back into the presynaptic terminal by the norepinephrine transporter (NET). We therefore tested the sensitivity of GRAB NE1m to NET blockade using desipramine in acute brain slices. In the presence of desipramine, electrical stimuli caused larger fluorescence responses in GRAB NE1m -expressing neurons compared with ACSF alone ( Figure 4E ). Moreover, desipramine significantly slowed down the decay kinetics of fluorescence signals, consistent with reduced reuptake of extracellular NE into the presynaptic terminal. To rule out the possibility that the change in the fluorescence response was caused by synaptic modulation over time, we applied repetitive electrical stimuli at 5-min intervals to GRAB NE1m -expressing neurons and found that the stimulation-evoked response was stable for at least 40 min ( Figure 4F ). Finally, we examined the specificity of the stimulation-induced response. Compared with a robust response in control conditions, the a-adrenergic antagonist yohimbine blocked the response; moreover, no response was elicited in LC neurons expressing GRAB NEmut or in LC neurons expressing a dopamine sensor (GRAB DA1m ; Figure 4G ). In contrast, cells expressing GRAB DA1m responded robustly to the applica-tion of DA, and the GRAB NE1m and GRAB DA1m responses were abolished by yohimbine or the dopamine receptor antagonist haloperidol, respectively ( Figure 4H ). Taken together, these data indicate that GRAB NE sensors are both sensitive and specific for detecting endogenous noradrenergic activity in LC neurons.
GRAB NE Sensors Detect Both Exogenous NE Application and Endogenous NE Release in Awake Zebrafish
Zebrafish is a genetically accessible vertebrate species and optically transparent during development, thus serving as a suitable model for in vivo imaging. We generated the transgenic zebrafish line Tg(HuC:GRAB NE1m ), which pan-neuronally expressed the GRAB NE1m sensor. Pan-neuronal expression was confirmed by GRAB NE1m basal fluorescence on the cell membrane of neurons throughout the brain ( Figure 5A ). Bath application of 50 mM NE-but not DA at the same concentrationelicited a robust increase in fluorescence intensity that was blocked completely by the subsequent application of 50 mM yohimbine ( Figures 5B-5D ). In addition, a separate zebrafish line expressing GRAB NEmut did not respond to NE ( Figures 5C  and 5D ).
Next, we investigated whether GRAB NE1m can be used to measure the dynamics of endogenous noradrenergic activity induced by a salient stimulus. Visual looming triggers a robust escape response in zebrafish (Berridge and Waterhouse, 2003; Li et al., 2018) . We applied repeated looming stimuli during confocal imaging to record the fluorescence of GRAB NE1m -expressing neurites in the optic tectum ( Figure 5E ). Each looming stimulus induced a time-locked increase in GRAB NE1m fluorescence, which was blocked by bath application of yohimbine but unaffected by the b-adrenergic receptor antagonist ICI 118,551 ( Figures 5F and 5G) . Similarly, looming stimuli induced a time-locked, repeatable fluorescence increase in GRAB NE1h transgenic zebrafish (Figures S5A and S5B) . In contrast, the same looming stimuli had no effect in zebrafish expressing GRAB NEmut (Figures 5F and 5G ). In addition, adding the NE reuptake inhibitor desipramine slowed the decay of the fluorescence signal ( Figure 5H ). By sparsely expressing GRAB NE1m in individual neurons in zebrafish larvae via transient transfection, we were also able to record robust signals at single-cell resolution in response to repetitive looming stimuli ( Figures 5I-5K ), confirming that our GRAB NE sensors can be used to sense NE release at the single-cell level with high spatiotemporal resolution. Finally, by expressing jRGECO1a, we compared both spontaneous and looming-evoked calcium activities in the optic tectum between zebrafish with or without GRAB NE1m expression and observed no significant difference in activity (Figures S5C1-S5C3 and  5L ), suggesting no adverse effects when expressing GRAB NE sensors in vivo. Taken together, these data indicate that GRAB NE sensors are sensitive and specific for detecting in vivo NE release in a common model system.
GRAB NE1m Detects Optogenetically Evoked NE Release in Freely Moving Mice
Having demonstrated proof of concept in a relatively simple in vivo vertebrate system, we next examined whether the GRAB NE sensors can be used to monitor noradrenergic activity in the mammalian brain. We virally expressed GRAB NE1m (non-Cre dependent) together with the optogenetic actuator C1V1 (Cre-dependent) in the LC of Th-Cre mice ( Figure 6A ). Optogenetic stimulation of LC noradrenergic neurons using 561-nm laser pulses reliably evoked an increase in GRAB NE1m fluorescence in fiber photometry recording of freely moving mice. Moreover, intraperitoneal (i.p.) injection of desipramine produced a slow progressive increase in basal GRAB NE1m fluorescence (consistent with an increase in extracellular NE levels) and caused an increase in the magnitude and decay time of the light-activated responses. Intraperitoneal (i.p.) injection of yohimbine abolished both the increase in basal GRAB NE1m fluorescence and the light-evoked responses ( Figures 6B-6D ). In contrast, treating mice with either GBR 12909 (a selective blocker of dopamine transporters) or eticlopiride (a specific D2R antagonist) had no effect on the light-evoked responses in GRAB NE1m fluorescence ( Figures 6C-6E ). To further test the selectivity of GRAB NE1m between NE and DA, we co-expressed GRAB NE1m and DIO-C1V1 both in the LC and in the substantia nigra pars compacta (SNc) of Th-Cre mice ( Figure 6F ). In these mice, optogenetic stimulation of dopaminergic neurons in the SNc did not cause any changes in the GRAB NE1m fluorescence in the SNc. In contrast, stimulating NE neurons in the LC produced a robust increase in GRAB NE1m fluorescence ( Figures  6F and 6G) . These results confirmed that the increase of GRAB NE1m fluorescence reflects the release of endogenous NE from noradrenergic neurons in the LC.
Using GRAB NE1m to Track Endogenous NE Dynamics in the Mouse Hypothalamus during Freely Moving Behaviors
In the brain, the hypothalamus mediates a variety of innate behaviors essential for survival, including feeding, aggression, mating, parenting, and defense (Hashikawa et al., 2016; Sokolowski and Corbin, 2012; Yang and Shah, 2016) . The hypothalamus receives extensive noradrenergic projections (Moore and Bloom, 1979; and expresses an abundance of a2-adrenergic receptors (Leibowitz, 1970; Leibowitz et al., 1982) . Microdialysis studies found that the hypothalamus is among the brain regions that release the high levels of NE during stress (Mc Quade and Stanford, 2000; Pacak et al., 1995; Shekhar et al., 2002; Tanaka, 1999) . To better understand NE dynamics in the hypothalamus under stress, we virally expressed hSyn-GRAB NE1m in the lateral hypothalamus of C57BL/6 mice. 3 weeks after virus injection, we performed fiber photometry recordings of GRAB NE1m fluorescence during a variety of stressful and non-stressful behaviors in freely moving mice ( Figure 7) .
During forced swimming and tail suspension tests, both of which were stressful, we observed a significant increase in GRAB NE1m fluorescence. During forced swimming, the fluorescence signal increased continuously, regardless of the animal's movements and started to decrease only after the animal was removed from the water (Figures 7C1, 7D1 , and 7E1). During the 60-s tail suspension test, the signal began to rise when the animal was first pursued by the experimenter's hand, increased continuously while the animal was suspended by the tail, and decreased rapidly back to baseline after the animal was returned to the ground (Figures 7C2, 7D2 , and 7E2). Additionally, when a human hand was placed in front of the animal, we observed a small and transient increase in GRAB NE1m fluorescence (Figures 7C3, 7D3, and 7E3) . In contrast, when a conspecific intruder of either the same or the opposite sex was introduced into the test animal's cage, we observed no change or a decrease in GRAB NE1m signals both during the initial introduction and subsequent social interactions, including social approach, being sniffed, or sniffing ( Figures 7C4, 7D4 , and 7E4 and 7C5, 7D5, and (B-D) Bath application of NE (50 mM), but not DA (50 mM), elicits a significant increase in fluorescence in the tectal neuropil of Tg(HuC:GRAB NE1m ) zebrafish, but not in GRAB NEmut zebrafish, and this increase is blocked by YO (50 mM), but not ICI 118,551 (50 mM). Pseudocolor images (B), raw traces (C), and statistical results (D) are shown. n = 7. (E-H) Visual looming stimuli evoke the release of endogenous NE in the midbrain of GRAB NE1m zebrafish, but not in GRAB NEmut zebrafish. The looming stimuli paradigm is shown in the left of (E). Raw traces (F) and statistical results (G) are shown. Where indicated, YO (50 mM) or ICI 118,551 (50 mM) was applied. Desipramine (Desi, 50 mM) application slowed the decay of looming-induced NE release (H). n = 6 for GRAB NEmut and n = 9 for the others. 7E5). Similarly, sniffing or eating palatable food (i.e., peanut butter) did not evoke detectable GRAB NE1m fluorescence signals (Figures 7C6, 7D6, and 7E6) . In control animals that expressed GRAB NEmut in the lateral hypothalamus, we observed no increase in fluorescence during all examined behavioral tests, including the forced swimming test and the tail suspension test, suggesting that movement artifacts contribute minimally to the detected signal change ( Figure S6 ). These data altogether provide evidence indicating that noradrenergic activity in the lateral hypothalamus occurs primarily under stressful conditions. (legend on next page) Finally, to confirm the specificity of the GRAB NE1m sensor for monitoring NE dynamics over other monoamine neurotransmitters, such as dopamine, we injected mice with a highly specific NET inhibitor atomoxetine (3 mg/kg i.p.) to inhibit the reuptake of NE. Although atomoxetine had no effect on the GRAB NE1m peak fluorescence during the tail suspension test, it significantly slowed the return of signal to its baseline after each tail suspension ( Figures 7F1, 7G1 , 7H1, and 7I1); in contrast, treating mice with the a-adrenergic receptor antagonist yohimbine (2 mg/kg, i.p.) both decreased GRAB NE1m peak fluorescence and significantly accelerated the return to baseline ( Figures 7F1, 7G1 , 7H1, and 7I1). Treating mice with either the selective DAT inhibitor GBR 12909 (10 mg/kg, i.p.) or the D2R antagonist sulpiride (50 mg/kg, i.p.) had no effect on the peak change in GRAB NE1m fluorescence or the time to return to baseline ( Figures 7F2,  7G2 , 7H2, and 7I2). In summary, these data demonstrate that our GRAB NE sensors are suitable for monitoring endogenous noradrenergic activity in real time, with high spatiotemporal precision, during freely moving behaviors in mammals.
DISCUSSION
Here, we report the development and validation of GRAB NE1m and GRAB NE1h , two genetically encoded NE sensors that can be used both in vitro and in vivo to monitor noradrenergic activity with high temporal and spatial resolution, high ligand specificity, and cell type specificity. In mouse acute brain slices, our GRAB NE sensors detected NE release from the LC in response to electrical stimulation. In zebrafish, the GRAB NE sensors reported looming-induced NE release with single-cell resolution. In mice, the GRAB NE sensors reported time-locked release of NE in the LC triggered by optogenetic stimulation and in hypothalamic NE levels during a variety of stress-related behaviors.
Compared with the existing methods for measuring NE, our GRAB NE sensors have distinct advantages. Our GRAB NE sensors have extremely high specificity for NE over most other neurotransmitters and chemical modulators, including DA (Figures 2H and 3F) . It has been difficult to distinguish NE from DA in vivo (e.g., by FSCV; Park et al., 2009; Robinson et al., 2003) , largely because of their structural similarities: they differ in only one hydroxyl group. GRAB NE1m has a roughly 1,000-fold-higher affinity for NE over DA when expressed in neurons, even better than the 85-fold difference of the wild-type a2-adrenergic receptor. Thus, our GRAB NE sensors provide new opportunities to probe the dynamics of noradrenergic activity with high specificity, which is particularly valuable when studying the many brain regions that receive overlapping dopaminergic and noradrenergic inputs. A notable property of GRAB NE sensors is their similar responses for NE and Epi. Almost all native human adrenergic receptors (a1AR/1BR/1DR, a2AR/2BR/2CR, and b1R/2R/3R) also respond non-discriminately to both NE and Epi (1-10 mM; Hoffman and Lefkowitz, 1980) . So, from the target cells' perspective, GRAB NE sensors provide a general tool to reveal when and where physiologically relevant levels of noradrenergic or adrenergic modulation occur. Discriminating NE versus Epi in the mammalian central nervous system is a relatively minor concern, because the specific enzyme (phenylethanolamine N-methyltransferase [PNMT]) that converts NE to Epi primarily exists in peripheral systems (e.g., adrenal medulla; Goldstein et al., 1972) , except for very small groups of neurons in human brain (Kitahama et al., 1985) .
Our GRAB NE sensors have extremely high sensitivity for NE. Specifically, their EC 50 for NE spans sub-micromolar levels. Their dynamic range is high: 150%-230% mean increase in fluorescence intensity upon binding saturating NE. By comparison, recently published FRET-based NE indicators produce a signal change of %10% under optimal conditions (Wang et al., 2018a (Wang et al., , 2018b . Thus, GRAB NE sensors have much improved characteristics for monitoring NE dynamics in vivo. Our sensors have brightness and photostability properties that rival EGFP, which permits stable recordings across extended experimental sessions. In addition, because they provide sub-second response kinetics and are genetically encoded, our GRAB NE sensors can non-invasively report noradrenergic activity in vivo with single-cell resolution and high recording rate ($30 Hz). Moreover, because GRAB NE sensors traffic to various surface membranes, including the cell body, dendrites, and axons, where they perform equally well, they are promising to provide subcellular spatial resolution, which is essential for understanding compartmental NE signaling in vivo. One caveat is that, because GRAB NE sensors are engineered from the a2A receptor, they may not be suitable for pharmacological investigation of a2A-receptor-related regulation.
Ligand binding to endogenous GPCRs drives G-protein activation and receptor internalization. If recapitulated in GRAB NE sensors, expression could interfere with endogenous signaling fidelity and disturb normal neuronal activity. We saw little (C1-E6) Representative traces (C1-C6), average per-stimulus histograms (D1-D6), and summary data (E1-E6) showing normalized GRAB NE1m fluorescence (DF/F) before and during the forced swim test (1) and before, between, and during the tail suspension test (2), the hand presentation test (3), social interaction with an intruder of the opposite sex (4) and the same sex (5), and presentation of peanut butter (6). n = 3 animals each. (F) Representative traces of GRAB NE1m fluorescence during the tail suspension test 10 min after saline injection, 25 min after atomoxetine (ATX) or YO injection, and 15 min after GBR 12909 or sulpiride (Sul) injection. (G-I) Averaged peri-stimulus histograms (G), peak change in GRAB NE1m fluorescence (H), and post-test decay time (I) measured during the tail suspension test after injection of the indicated compounds. n = 3 each. The Shapiro-Wilk normality test was performed; if the test revealed it followed a normal distribution, a paired Student's t test or one-way repeated-measures ANOVA followed by Tukey's multiple comparisons was performed. If the values did not follow a normal distribution, a non-parametric ANOVA (Friedman's test) was performed followed by Dunn's multiple comparisons test. In (C) and (D), the blue dotted lines represent the start of the stimulus and the red dotted lines represent the end of the trial. *p < 0.05, **p < 0.01, and ***p < 0.001. See also Figure S6 . evidence of downstream coupling to both G-protein-independent and G-protein-dependent pathways. The introduction of the cpEGFP moiety in the GRAB NE sensors resulted in undetectable engagement of arrestin-mediated desensitization and/or internalization, which suggests that the GRAB NE sensors do not inadvertently activate arrestin-dependent signaling and ensures more consistent surface expression of the sensors. With respect to G-protein-dependent signaling, we found that, although physiological levels of NE robustly induce a change in GRAB NE fluorescence, they do not significantly engage downstream G protein signaling (Figures 2J-2M) .
Noradrenergic projections throughout the brain originate almost exclusively from the LC, and the released NE plays a role in a wide range of behaviors, including cognition and the regulation of arousal, attention, and alertness (Berridge and Waterhouse, 2003; Li et al., 2018; . Interestingly, our fiber photometry recordings of GRAB NE sensors' fluorescence in the hypothalamus of freely behaving mice revealed specific changes in noradrenergic activity under stressful, but not non-stressful, conditions. These data are generally consistent with previous data obtained using microdialysis to measure NE (Mc Quade and Stanford, 2000; Pacak et al., 1995; Shekhar et al., 2002; Tanaka, 1999) . Nevertheless, it is worth noting that hypothalamus is a highly heterogeneous structure containing dozens of nuclei with diverse functions, it remains possible that NE is released during non-stressful conditions in regions outside of lateral hypothalamus. The spatial resolution and potential for cell type specificity of GRAB NE sensors should enable more precise investigation of NE signaling across hypothalamic nuclei in freely moving animals.
NE circuits of the LC receive heterogeneous inputs from a broad range of brain regions and send heterogeneous outputs to many brain regions . Congruously, altered noradrenergic activity is associated with a broad range of psychiatric conditions and neurodegenerative diseases, including ADHD, PD, depression, and anxiety (Marien et al., 2004) . The complexity of these disorders may, in part, reflect the complexity of noradrenergic circuits and signals, which cannot be fully dissected by previous tools. Therefore, the GRAB NE sensors we present here are more suitable for understanding the regulation and impact of noradrenergic activity during complex behaviors. Deploying these in concert with other cell-specific tools for reporting Patriarchi et al., 2018; Sun et al., 2018) and manipulating neurotransmitter levels Urban and Roth, 2015) will increase our understanding of the circuits and mechanisms that underlie brain functions in both health and disease.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Primary cultures
Rat cortical neurons were prepared from postnatal day 0 (P0) Sprague-Dawley rat pups (both male and female, randomly selected; Beijing Vital River). In brief, cortical neurons were dissociated from dissected P0 rat brains in 0.25% Trypsin-EDTA (GIBCO), plated on 12-mm glass coverslips coated with poly-D-lysine (Sigma-Aldrich), and cultured at 37 C in 5% CO 2 in neurobasal medium (GIBCO) containing 2% B-27 supplement, 1% GlutaMax, and 1% penicillin-streptomycin (GIBCO).
Cell lines
HEK293T cells were obtained from ATCC (CRL-3216) and verified based on their morphology under the microscope and by their growth curve. Stable cell lines expressing the wild-type a2-adrenergic receptor or various GRAB NE sensors were constructed by co-transfecting cells with the pPiggyBac plasmid carrying target genes with Tn5 transposase into a stable HEK293T-based cell line expressing chimeric Gaq/i and AP-TGFa (Inoue et al., 2012) . Cells that stably expressed the target genes were selected by treating with 2 mg/ml Puromycin (Sigma) after reaching 100% confluence. The HTLA cells used for the TANGO assay stably express a tTA-dependent luciferase reporter and a b-arrestin2-TEV fusion gene and were a gift from Bryan L. Roth (Kroeze et al., 2015) . All cell lines were cultured at 37 C in 5% CO 2 in DMEM (GIBCO) supplemented with 10% (v/v) fetal bovine serum (GIBCO) and 1% penicillin-streptomycin (GIBCO).
Mice/Rats
All procedures regarding animals were approved by the respective Animal Care and Use Committees at Peking University, New York University, University of Southern California, University of Virginia and the US National Institutes of Health and were performed in compliance with the US National Institutes of Health guidelines for the care and use of laboratory animals. Wild-type Sprague-Dawley rat pups (P0) were used to prepare cultured cortical neurons and pups (P6-7) were used to prepare cultured hippocampal slices. Wild-type C57BL/6 and Th-Cre mice (MMRRC_031029-UCD, obtained from MMRRC) were used to prepare the acute brain slices and for the in vivo mouse experiments. Experimental Th-Cre mice were produced by breeding Th-Cre hemizygous BAC transgenic mice with C57BL/6J mice. All animals were housed in the animal facility and were family-housed or pair-housed in a temperaturecontrolled room with a 12hr-12h light-dark cycle (10 pm to 10 am light) with food and water provided ad libitum. All in vivo mouse experiments were performed using 2-12-month-old mice of both sexes.
Zebrafish
The background strain for these experiments is the albino strain slc45a2 b4 . To generate transgenic zebrafish, both the pTol2-HuC:GRAB NE1m plasmid and Tol2 mRNA were co-injected into single-cell stage zebrafish eggs, and the founders of Tg(HuC:GRAB NE1m ) were screened at adult stage. Tg(HuC:GRAB NE1h ) and Tg(HuC:GRAB NEmut ) were generated as described above by using the pTol2-HuC:GRAB NE1h and pTol2-HuC:GRAB NEmut plasmid, respectively. Adult fish and larvae were maintained on a 14h-10h light-dark cycle at 28 C. All experimental larvae were raised to 6-8 days post-fertilization (dpf) in 10% Hank's solution, which consisted of (in mM): 140 NaCl, 5.4 KCl, 0.25 Na 2 HPO 4 , 0.44 KH 2 PO 4 , 1.3 CaCl 2 , 1.0 MgSO 4 , and 4.2 NaHCO 3 (pH 7.2). Larval zebrafish do not undergo sex differentiation prior to 1 month post-fertilization (Singleman and Holtzman, 2014) .
METHOD DETAILS
Molecular cloning
The molecular clones used in this study were generated by Gibson Assembly (Gibson et al., 2009 ) using DNA fragments amplified using primers (Thermo Fisher Scientific, the sequence of all clones. All cDNAs encoding the candidate GRAB NE sensors were cloned into the pDisplay vector (Invitrogen) with an upstream IgK leader sequence and a downstream IRES-mCherry-CAAX cassette to label the cell membrane. The cDNAs of select adrenergic receptor candidates were amplified from the human GPCR cDNA library (hORFeome database 8.1), and cpEGFP from GCaMP6s was inserted into the third intracellular loop (ICL3). The insertion sites for the GRAB NE sensors were screened by truncating the ICL3 of the a2-adrenergic receptor at the 10-amino acid (AA) level, followed by fine-tuning at the 1-AA level. Coupling linkers were randomized by PCR amplification using randomized NNB codons in target sites. Other cDNAs used to express the GRAB NE sensors in neurons were cloned into the pAAV vector using the human synapsin promoter (hSyn) or TRE promoter. pAAV-hSyn-tTA was used to drive expression of the TRE promoter. The plasmids carrying compartmental markers were cloned by fusing EGFP-CAAX, RFP-CAAX (mScarlet), KDELR-EGFP, PSD95-RFP, and synaptophysin-RFP into the pDest vector. The sensors were also subcloned into Sindbis viral vector for cultured hippocampal slices expression. To characterize signaling downstream of the GRAB NE sensors, we cloned the sensors and the wild-type a2-adrenergic receptor into the pTango and pPiggyBac vector, respectively. A hyperactive pig-gyBac transposase was generated by introducing two mutations into pCS7-PiggyBAC (VIEWSOLID BIOTECH) (Yusa et al., 2011) . GRAB NE1m -SmBit and a2AR-SmBit constructs were derived from b2AR-SmBit (Wan et al., 2018) using a BamHI site incorporated upstream of the GGSG linker. LgBit-mGsi was a gift from Nevin A. Lambert.
Expression of GRAB NE sensors in cultured cells and in vivo
The GRAB NE sensors were characterized in HEK293T cells and cultured rat cortical neurons, with the exception of the TANGO assay and TGFa shedding assay. HEK293T cells were passaged with Trypsin-EDTA (0.25%, phenol red; GIBCO) and plated on 12-mm size 0 glass coverslips in 24-well plates and grown to $70% confluence for transfection. HEK293T cells were transfected by incubating cells with a mixture containing 1 mg of DNA and 3 mg of PEI for 6 h. Imaging was performed 24-48 h after transfection. Cells expressing GRAB NE sensors for screening were plated on 96-well plates (PerkinElmer). Cultured neurons were transfected using the calcium phosphate method at 7-9 DIV. In brief, the neurons were incubated for 2 h in a mixture containing 125 mM CaCl 2 , HBS (pH 7.04), and 1.5 mg DNA. The DNA-Ca 3 (PO4) 2 precipitate was then removed from the cells by washing twice with warm HBS (pH 6.80). Cells were imaged 48 h after transfection.
For in vivo expression, the mice were anesthetized by an i.p. injection of 2,2,2-tribromoethanol (Avetin, 500 mg/kg body weight, Sigma-Aldrich) or under isoflurane anesthesia, and then placed in a stereotaxic frame for injection of AAVs using a Nanoliter 2000 Injector (WPI) or Nanoject II (Drummond Scientific) microsyringe pump. For the experiments shown in Figures 4, 6 , and S4J-S4M, the AAVs containing hSyn-GRAB NE1m/NE1h/NEmut/DA1m and Ef1a-DIO-C1V1-YFP were injected into the LC (AP: À5.45 mm relative to Bregma; ML: ± 1.25 mm relative to Bregma; and DV: À2.25 mm from the brain surface) or SNc (AP: À3.1 mm relative to Bregma; ML: ± 1.5 mm relative to Bregma; and DV: À3.8 mm from the brain surface) of wild-type or Th-Cre mice. For experiments shown in Figures S4A-S4I , AAVs containing hSyn-tTA and TRE-GRAB NE1h were injected into the dentate gyrus (AP: À1.8 mm relative to Bregma; ML: ± 0.8 mm relative to Bregma; and DV: À2.0 mm from the brain surface) of wild-type mice. For the experiments shown in Figures 7 and S6 , 100 nL of AAV9-hSyn-GRAB NE1m or AAV9-hSyn-GRAB NEmut (Vigene, 1x10 13 titer genomic copies per ml) were unilaterally into the hypothalamus (AP: À1.7 mm relative to Bregma; ML: 0.90 mm relative to Bregma; and DV: À6.05 mm from the brain surface) of wild-type (C57BL/6) mice at a rate of 10 nl/min.
Fluorescence imaging of HEK293T cells and cultured neurons
HEK293T cells and cultured neurons expressing GRAB NE sensors were screened using an Opera Phenix high-content imaging system (PerkinElmer) and imaged using an inverted Ti-E A1 confocal microscope (Nikon). A 60x/1.15 NA water-immersion objective was mounted on the Opera Phenix and used to screen GRAB NE sensors with a 488-nm laser and a 561-nm laser. A 525/50 nm and a 600/30 nm emission filter were used to collect the GFP and RFP signals, respectively. HEK293T cells expressing GRAB NE sensors were first bathed in Tyrode's solution and imaged before and after addition of the indicated drugs at the indicated concentrations. The change in fluorescence intensity of the GRAB NE sensors was calculated using the change in the GFP/RFP ratio. For confocal microscopy, the microscope was equipped with a 40x/1.35 NA oil-immersion objective, a 488-nm laser, and a 561-nm laser. A 525/50 nm and a 595/50 nm emission filter were used to collect the GFP and RFP signals, respectively. GRAB NE -expressing HEK293T cells and neurons were perfused with Tyrode's solutions containing the drug of interest in the imaging chamber. The photostability of GRAB NE sensors and EGFP was measured using a confocal microscope (for 1-photon illumination) equipped with a 488-nm laser at a power setting of $350 mW, and using a FV1000MPE 2-photon microscope (Olympus, 2-photon illumination) equipped with a 920-nm laser at a power setting of $27.5 mW. The illuminated region was the entire HEK293T cell expressing the target protein, with an area of $200 mm 2 . Photolysis of 100 mM NPEC-caged-NE (Santa Cruz) was performed by combining fast scanning with a 76-ms pulse of 405-nm laser illumination by a confocal microscope. 10 mM YO was used to specific block the NE-induced fluorescence response. 100 mM NE and 200 mM yohimbine were used in determination of on or off kinetics in rapid perfusion experiments.
TANGO assay NE at various concentrations (ranging from 0.1 nM to 100 mM) was applied to a2AR-expressing or GRAB NE1m -/ GRAB NE1h -expressing HTLA cells (Kroeze et al., 2015) . The cells were then cultured for 12 h to allow expression of the luciferase gene. Furimazine (NanoLuc Luciferase Assay, Promega) was then applied to a final concentration of 5 mM, and luminescence was measured using a VICTOR X5 multilabel plate reader (PerkinElmer).
TGFa shedding assay TGF shedding assay was performed as previously described (Inoue et al., 2012) . Stable cell lines expressing Gai-AP-TGFa together with the wild-type a2AR or GRAB NE1m were plated in a 96-well plate and treated by the addition of 10 mL of a 10x solution of NE in each well, yielding a final NE concentration ranging from 0.1 nM to 100 mM. Absorbance at 405 nm was read using a VICTOR X5 multilabel plate reader (PerkinElmer). TGFa release was calculated as described previously (Inoue et al., 2012) . Relative levels of G protein activation were calculated as the TGFa release of GRAB NE sensors normalized to the release mediated by wild-type a2AR.
FSCV
Fast-scan cyclic voltammetry (FSCV) was performed using 7-mm carbon fiber microelectrodes. Voltammograms were measured with a triangular potential waveform from À0.4 V to +1.1 V at a scan rate of 400 V/s with a 100-ms interval. The carbon fiber microelectrode was held at À0.4 V between scans. Voltammograms measured in the presence of various different drugs in Tyrode's solution were generated using the average of 200 scans followed by the subtraction of the average of 200 background scans. Currents were recorded using the Pinnacle tethered FSCV system (Pinnacle Technology). Pseudocolor plots were generated using Pinnacle FSCV software.
Luciferase complementation assay
The luciferase complementation assay was performed as previously described (Wan et al., 2018) . In brief, $48h after transfection the cells were washed with PBS, harvested by trituration, and transferred to opaque 96-well plates containing diluted NE solutions from 1 nM to 100 mM. Furimazine (NanoLuc Luciferase Assay, Promega) was added to each well immediately prior to performing the measurements with Nluc.
Fluorescence imaging of GRAB NE sensors in brain slices Fluorescence imaging of acute brain slices was performed as previously described (Sun et al., 2018) . In brief, the animals were anesthetized with Avertin, and acute brain slices containing the LC region or the hippocampus region were prepared in cold slicing buffer containing (in mM): 110 choline-Cl, 2.5 KCl, 1.25 NaH 2 PO 4 , 25 NaHCO 3 , 7 MgCl 2 , 25 glucose, and 2 CaCl 2 . Slices were allowed to recover at 35 C in oxygenated Ringers solution containing (in mM): 125 NaCl, 2.5 KCl, 1.25 NaH 2 PO 4 , 25 NaHCO 3 , 1.3 MgCl 2 , 25 glucose, and 2 CaCl 2 for at least 40 min before experiments. An Olympus FV1000MPE two-photon microscope equipped with a 40x/0.80 NA water-immersion objective and a mode-locked Mai Tai Ti:Sapphire laser (Spectra-Physics) tuned to 920 nm were used for imaging the slices. For electrical stimulation, a concentric electrode (model #CBAEC75, FHC) was positioned near the LC region, and the imaging and stimuli were synchronized using an Arduino board controlled using a custom-written program. The imaging speed was set at 0.148 s/frame with 128 3 96 pixels in each frame. The stimulation voltage was set at $6 V, and the duration of each stimulation was typically 1 ms. Drugs were either delivered via the perfusion system or directly bath-applied in the imaging chamber. For the calcium imaging experiments, the acute brain slices expressing GRAB NE1h were prepared and bath loaded with red calcium dye Cal590 (20 mM, AAT Bioquest Inc., Sunnyvale, CA) for 1h, and subsequently washed in ACSF for 30 mins before conducting two-photon imaging. Cal590 dye was excited with two-photon laser at 920 nm, and 90 mM KCl was perfused to stimulate calcium signals.
For immunostaining of brain sections, GRAB NE -expressing mice were anesthetized with Avetin, and the heart was perfused with 0.9% NaCl followed by 4% paraformaldehyde (PFA). The brain was then removed, placed in 4% PFA for 4 h, and then cryoprotected in 30% (w/v) sucrose for 24 h. The brain was embedded in tissue-freezing medium, and 50-mm thick coronal sections were cut using a Leica CM1900 cryostat (Leica, Germany). A chicken anti-GFP antibody (1:500, Abcam, #ab13970) was used to label GRAB NE , and a rabbit anti-DBH antibody (1:50, Abcam, #ab209487) was used to label adrenergic terminals in the hippocampus. Alexa 488conjugated goat-anti-chicken and Alexa-555-conjugated goat-anti-rabbit secondary antibodies were used, and the nuclei were counterstained with DAPI. The sections were imaged using a confocal microscope (Nikon).
Electrophysiology
Cultured slices were prepared from P6À7 rats following the previous studies (Wang et al., 2015; Zhang et al., 2018) . In brief, the hippocampus were dissected out in ice-cold HEPES-buffered Hanks' solution (pH 7.35) under sterile conditions, sectioned into 400 mm slices on a tissue chopper, and explanted onto a Millicell-CM membrane (0.4-mm pore size; Millipore, MA). The membranes were then placed in 750 ml of MEM culture medium, contained (in mM): HEPES 30, heat-inactivated horse serum 20%, glutamine 1.4, D-glucose 16.25, NaHCO 3 5, CaCl 2 1, MgSO 4 2, insulin 1 mg/ml, ascorbic acid 0.012% at pH 7.28 and osmolarity 320. Cultured slices were maintained at 35 C, in a humidified incubator (ambient air enriched with 5% CO 2 ).
Simultaneous dual whole-cell recordings were obtained from two nearby infected and non-infected hippocampal CA1 pyramidal neurons under visual guidance using fluorescence and transmitted light illumination. The patch recording pipettes (4À7 MU) were filled with intracellular solution 120 mM potassium gluconate, 4 mM KCl, 10 mM HEPES, 4 mM MgATP, 0.3 mM Na 3 GTP, 10 mM sodium phosphocreatine and 0.5% biocytin (pH 7.25) for voltage-clamp recordings. Bath solution (29 ± 1.5 C) contained (in mM): NaCl 119, KCl 2.5, CaCl 2 4, MgCl 2 4, NaHCO 3 26, NaH 2 PO 4 1 and glucose 11, at pH 7.4 and gassed with 5% CO 2 /95% O 2 . Whole-cell recordings were made with up to two Axopatch-200B patch clamp amplifiers (Molecular Devices, Sunnyvale, CA).
Fluorescence imaging of zebrafish Tg(HuC:GRAB NE1m ) and Tg(HuC:GRAB NE1h ) zebrafish larvae were imaged by using an upright confocal microscope (Olympus FV1000, Japan) equipped with a 20x/0.95 NA water-dipping objective. The larvae were first paralyzed with a-bungarotoxin (100 mg/ml, Sigma), mounted dorsal side up in 1.5% low melting-point agarose (Sigma), and then perfused with an extracellular solution consisting of (in mM) 134 NaCl, 2.9 KCl, 4 CaCl 2 , 10 HEPES, and 10 glucose (290 mOsmol/L, pH 7.8). Images were acquired at 1-2 Hz with a view field of 800 3 800 pixels and a voxel size was 0.62 3 0.62 3 2.0 mm 3 (x 3 y 3 z). To detect the sensor's response to exogenous NE, 50 mM L-(-)-norepinephrine (+)-bitartrate salt monohydrate (Sigma) in 5 mM L-ascorbic acid and 50 mM yohimbine hydrochloride (TOCRIS) were sequentially applied to the bath. To detect endogenous NE release, visual looming stimuli, which mimic approaching objects or predators (Yao et al., 2016) were projected to the larvae under a red background. Each trial lasted 5 s, and 5 trials were performed in a block, with a 90 s interval between trials. To examine the specificity of responses, ICI 118,551 hydrochloride (50 mM, Sigma), yohimbine hydrochloride (50 mM, TOCRIS), and desipramine hydrochloride (50 mM, Sigma) were applied. Looming stimuli in transiently transfected HuC:GRAB NE1m zebrafish were measured at single-cell resolution by using the same conditions described above. To examine whether overexpression of GRAB NE sensors affect neuronal activities, we performed spontaneous and looming-evoked calcium imaging for tectal neurons in Tg(HuC:NES-jRGECO1a) with or without HuC:GRAB NE1m expression. Ten minutes' spontaneous calcium activities were recorded after 15-min habituation.
Fiber photometry recording in freely moving mice during optical stimulation
In the all-optic experiments shown in Figure 6 , multimode optical fiber probes (105/125 mm core/cladding) were implanted into the LC (AP: À5.45 mm relative to Bregma; ML: ± 0.85 mm relative to Bregma; and DV: À3.5 mm from the brain surface) and the SNc (AP: À3.1 mm relative to Bregma; ML: ± 1.5 mm relative to Bregma; and DV: À3.85 mm from the brain surface) in mice four weeks after viral injection. Fiber photometry recording in the LC and/or SNc was performed using a 473-nm laser with an output power of 25 mW measured at the end of the fiber. The measured emission spectra were fitted using a linear unmixing algorithm (https://www.niehs. nih.gov/research/atniehs/labs/ln/pi/iv/tools/index.cfm). The coefficients generated by the unmixing algorithm were used to represent the fluorescence intensities of various fluorophores (Meng et al., 2018) . To evoke C1V1-mediated NE/DA release, pulse trains (10-ms pulses at 20 Hz for 1 s) were delivered to the LC/SNc using a 561-nm laser with an output power of 9.9 mW measured at the end of the fiber.
Fiber photometry recording in mice during behavioral testing
For the experiments in Figures 7 and S6 , a fiber photometry recording set-up was generated and used as previously described . GRAB NE1m was injected into the lateral hypothalamus (Bregma AP: À1.7mm; ML: 0.90 mm; DV: À6.05 mm) of C57BL/6 mice in a volume of 100 nL containing AAV9-hSyn-GRAB NE1m (Vigene, 1x10 13 titer genomic copies per ml) or AAV9-hSyn-GRAB NEmut (Vigene, 1x10 13 titer genomic copies per ml) at 10 nl/min. A 400-mm optic fiber (Thorlabs, BFH48-400) housed in a ceramic ferrule (Thorlabs, SFLC440-10) was implanted 0.2 mm above the injection site. The virus was left to incubate for three weeks. Prior to fiber photometry recording, a ferrule sleeve was used to connect a matching optic fiber to the implanted fiber. For recordings, a 400-Hz sinusoidal blue LED light (30 mW; M470F1 driven by an LEDD1B driver; both from Thorlabs) was bandpassfiltered (passing band: 472 ± 15 nm, Semrock, FF02-472/30-25) and delivered to the brain in order to excite GRAB NE1m . The emission light passed through the same optic fiber, through a bandpass filter (passing band: 534 ± 25 nm, Semrock, FF01-535/50), and into a Femtowatt Silicon Photoreceiver, which recorded the GRAB NE1m emission using an RZ5 real-time processor (Tucker-Davis Technologies). The 400-Hz signals from the photoreceiver were extracted in real time using a custom-written program (Tucker-Davis Technologies) and used to reflect the intensity of the GRAB NE1m fluorescence signal.
Behavioral assays
All behavioral tests were performed at least 1 h after the onset of the dark cycle. For the tail suspension test, each mouse was gripped by the tail and lifted off the bottom of its cage six times for 60 s each, with at least 1 min between each lift. For the forced swim test, the mouse was gently placed in a 1000 mL conical flask containing lukewarm water and removed after 4-6 min. After removal from the water, the mouse was gently dried with paper towels and placed in the home cage on a heating pad. For conspecific assays, an adult C57BL/6 group-housed mouse of either sex was placed inside the test mouse's cage for 10 min. No sexual behavior or aggressive behavior was observed during the interaction. For the food assay, $4g of peanut butter was placed in the cap of a 15 mL plastic tube and placed inside of the test mouse's cage for 10 min. During that period, the test mouse was free to explore, sniff, and eat the peanut butter. All videos were acquired at 25 frames per second and manually annotated frame-by-frame using a custom MATLAB program (Lin et al., 2011) . ''Approach'' refers to the period in which the subject mouse walks toward the intruder mouse. ''Sniff'' refers to the time in which the subject mouse sniffs the conspecific intruder. ''Being sniffed'' refers to the period in which the subject mouse is being sniffed by the conspecific intruder. ''Contact'' with the social stimulus refers to the period in which the test mouse sniffed or was sniffed by the intruder. ''Contact'' with the peanut butter refers to the period in which the test mouse sniffed or ate the peanut butter. ''Lift'' refers to the period in which the experimenter gripped the mouse's tail and lifted the mouse into the air.
QUANTIFICATION AND STATISTICAL ANALYSIS
For the imaging experiments using cultured HEK293T cells, primary neurons, and brain slices, images were first imported to ImageJ software (National Institutes of Health) for fluorescence intensity readouts, and then analyzed using MATLAB (MathWorks) with a custom-written script or Origin Pro (OriginLab). The fluorescence response traces in the brain slices shown in Figure 4 were processed with 3x binning and then plotted.
Time-lapse images of the zebrafish were analyzed using Fiji to acquire the fluorescence intensity in the region of interest (ROI) in each frame. A custom-written MATLAB program was then used to calculate the change in fluorescence intensity (DF/F 0 ) as (F t ÀF 0 )/ F 0 , where F t was the fluorescence intensity at time t and F 0 was the average fluorescence intensity during the entire time window. Statistical analyses were performed using GraphPad Prism 6 and Origin Pro (OriginLab).
For the fiber photometry data shown in Figure 7 , the MATLAB function ''msbackadj'' with a moving window of 25% of the total recording duration was first applied to obtain the instantaneous baseline signal (F baseline ). The instantaneous DF/F was calculated as (F raw -F baseline )/F baseline , and a peri-stimulus histogram (PSTH) was calculated by aligning the DF/F signal of each trial to the onset of the behavior of interest. The response elicited during a behavior was calculated as the average DF/F during all trials of a given behavior. The response between behavioral periods was calculated as the average DF/F between two behavioral episodes excluding 4 s immediately before the behavior's onset, as some uncontrolled and/or unintended events (e.g., chasing the animal before the tail suspension test) may have occurred during that period. The baseline signal was calculated as the average DF/F 100 s prior to the start of the behavioral test. The peak response after each drug injection was calculated as the average maximum DF/F during all tail suspension trials. The decay time was calculated as the average time required to reach half of the peak response.
Except where indicated otherwise, group differences were analyzed using the Student's t test, Wilcoxon matched-pairs signed rank test, Shapiro-Wilk normality test, one-way ANOVA test, or Friedman's test. Except where indicated otherwise, all summary data are presented as the mean ± SEM.
DATA AND SOFTWARE AVAILABILITY
The custom-written MATLAB programs using in this study will be provided upon request to the corresponding author. during the forced swim test (1), and before, between and during the tail suspension test 154
(2), the hand presentation test (3), social interaction with an intruder of the opposite sex 155 (4) , an intruder of the same sex (5) and presentation of peanut butter (6). n = 3 animals 156
each. 157
The Shapiro-Wilk normality test was performed; if the test revealed it followed a normal 158 distribution, a paired Student's t-test or one-way repeated measures ANOVA followed by 159
Tukey's multiple comparisons was performed. If the values did not follow a normal 160 distribution, a non-parametric ANOVA (Friedman's test) was performed followed by 161
Dunn's multiple comparisons test. In (C) and (D), the blue dotted lines represent the start 162 of the stimulus, and the red dotted lines represent the end of the trial. 163 *p < 0.05 and **p < 0.01. 164
